270 related articles for article (PubMed ID: 24059587)
1. microRNA in the development of diabetic complications.
McClelland AD; Kantharidis P
Clin Sci (Lond); 2014 Jan; 126(2):95-110. PubMed ID: 24059587
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
3. Potential role of blood microRNAs as non-invasive biomarkers for early detection of asymptomatic coronary atherosclerosis in obese children with metabolic syndrome.
Omran A; Elimam D; He F; Peng J; Yin F
Med Hypotheses; 2012 Dec; 79(6):889-93. PubMed ID: 23062773
[TBL] [Abstract][Full Text] [Related]
4. The role of inflammatory cytokines in diabetes and its complications.
King GL
J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007
[TBL] [Abstract][Full Text] [Related]
5. Are extracellular microRNAs involved in type 2 diabetes and related pathologies?
Rome S
Clin Biochem; 2013 Jul; 46(10-11):937-45. PubMed ID: 23499584
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
7. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
[TBL] [Abstract][Full Text] [Related]
8. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
Alvarez ML; Distefano JK
Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs in the modulation of diabetic retinopathy.
Mastropasqua R; Toto L; Cipollone F; Santovito D; Carpineto P; Mastropasqua L
Prog Retin Eye Res; 2014 Nov; 43():92-107. PubMed ID: 25128741
[TBL] [Abstract][Full Text] [Related]
10. Role of microRNAs in obesity and the metabolic syndrome.
Heneghan HM; Miller N; Kerin MJ
Obes Rev; 2010 May; 11(5):354-61. PubMed ID: 19793375
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in diabetes and diabetes-associated complications.
Lorenzen J; Kumarswamy R; Dangwal S; Thum T
RNA Biol; 2012 Jun; 9(6):820-7. PubMed ID: 22664916
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of diabetic complications.
Forbes JM; Cooper ME
Physiol Rev; 2013 Jan; 93(1):137-88. PubMed ID: 23303908
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of dietary restriction in type 2 diabetic rats: the role of adipokines on inflammation and insulin resistance.
Crisóstomo J; Rodrigues L; Matafome P; Amaral C; Nunes E; Louro T; Monteiro P; Seiça R
Br J Nutr; 2010 Jul; 104(1):76-82. PubMed ID: 20178670
[TBL] [Abstract][Full Text] [Related]
14. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.
Björnholm M; Zierath JR
Biochem Soc Trans; 2005 Apr; 33(Pt 2):354-7. PubMed ID: 15787605
[TBL] [Abstract][Full Text] [Related]
15. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
[TBL] [Abstract][Full Text] [Related]
16. CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes.
Ling HY; Ou HS; Feng SD; Zhang XY; Tuo QH; Chen LX; Zhu BY; Gao ZP; Tang CK; Yin WD; Zhang L; Liao DF
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):e32-9. PubMed ID: 19473196
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA regulatory networks in human adipose tissue and obesity.
Arner P; Kulyté A
Nat Rev Endocrinol; 2015 May; 11(5):276-88. PubMed ID: 25732520
[TBL] [Abstract][Full Text] [Related]
18. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
[TBL] [Abstract][Full Text] [Related]
19. Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation?
Sell H; Eckel J
Proc Nutr Soc; 2009 Nov; 68(4):378-84. PubMed ID: 19698204
[TBL] [Abstract][Full Text] [Related]
20. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.
Cooper ME
Am J Hypertens; 2004 Dec; 17(12 Pt 2):31S-38S. PubMed ID: 15607433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
